ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 229

$934K Total Retail Price of All Prescriptions

Rank: 3 out of 229

796 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 796 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 14,320 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 818 702 1 3
LEVOTHYROXINE SODIUM 732 685 2 1
LISINOPRIL 722 642 3 2
FUROSEMIDE 518 483 4 8
POTASSIUM CHLORIDE 510 479 5 18
HYDROCODONE-ACETAMINOPHEN 507 429 S3 6 7
OMEPRAZOLE 471 419 7 4
DONEPEZIL HCL 413 413 8 29
METOPROLOL TARTRATE 368 318 9 13
CIPROFLOXACIN HCL 317 274 10 58
AZITHROMYCIN 305 260 11 53
AMLODIPINE BESYLATE 304 279 12 5
METFORMIN HCL 293 226 13 6
WARFARIN SODIUM 292 263 14 17
SERTRALINE HCL 210 202 15 22
GLYBURIDE 197 190 R 16 57
HYDROCHLOROTHIAZIDE 182 174 17 9
GABAPENTIN 169 152 18 10
LANTUS 152 134 19 40
NAMENDA 148 148 20 39
PRAVASTATIN SODIUM 147 116 21 25
RISPERIDONE 144 137 22 95
RANITIDINE HCL 133 107 23 32
METOPROLOL SUCCINATE 130 124 24 16
TAMSULOSIN HCL 130 130 24 24
MELOXICAM 129 117 26 45
ALLOPURINOL 128 101 27 27
ATENOLOL 124 123 28 19
CLONIDINE HCL 121 121 29 69
ENALAPRIL MALEATE 120 107 30 54
METHYLPREDNISOLONE 118 107 31 197
ALENDRONATE SODIUM 118 116 31 14
ATORVASTATIN CALCIUM 115 94 33 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 77 34 28
CLOPIDOGREL 114 105 34 44
PHENYTOIN SODIUM EXTENDED 114 95 34 136
LOSARTAN POTASSIUM 108 104 37 12
TRAZODONE HCL 102 96 38 34
RAMIPRIL 102 102 38 167
FLUOXETINE HCL 100 91 40 41
OLANZAPINE 95 82 41 109
DIOVAN 95 95 41 42
INSULIN SYRINGE 92 72 43 83
MIRTAZAPINE 90 90 44 52
PREDNISONE 90 84 44 35
SPIRIVA 89 89 46 76
ADVAIR DISKUS 86 79 47 47
PROAIR HFA 85 80 48 38
CYMBALTA 84 84 49 64
CARVEDILOL 82 66 50 31
PLAVIX 79 72 51 72
DIGOXIN 79 74 51 92
SYNTHROID 77 73 53 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 62 54 111
NOVOLIN R 65 62 55 164
EXELON 65 65 55 162
LEVEMIR 64 57 57 126
TRAMADOL HCL 63 48 58 26
HYDROXYZINE HCL 62 45 R 59 165
NEXIUM 61 51 60 48
LOVASTATIN 59 53 61 11
FLUTICASONE PROPIONATE 58 55 62 23
ROPINIROLE HCL 58 52 62 96
CITALOPRAM HBR 57 55 64 21
NIFEDICAL XL 57 51 64 208
PREMARIN 55 51 R 66 101
FLOVENT HFA 54 53 67 115
HYDROCORTISONE 53 51 68 288
FINASTERIDE 52 52 69 55
SULINDAC 52 51 69 224
CEPHALEXIN 52 47 69 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.